Researchers used artificial intelligence to treat cancer and ageing
Drug Discovery World (DDW) - 16-Nov-2023KDM1A emerged as dual-action therapeutic target for both
Previously the Live Forever Club — same community, now with a sharper mission for life extension
Global business review of drug discovery and development
Drug Discovery World is the multi-platform global voice for the drug discovery community. From research stage to clinical trials the brand covers the scientific and commercial process involved in getting a drug to market – research, target identification and validation, drug molecule identification, lead molecule optimisation, pre-clinical research, clinical trial authorisation and application, and clinical trials phase I and II. DDW readers learn how to turn science into business.
DDW is available as a quarterly printed publication, online and as a free-to-download app containing trusted content as well as premium hand-picked intelligence for anyone involved in drug discovery and development. Readers can also sign up for our free weekly e-newsletter.
Visit website: https://www.ddw-online.com/
Details last updated 22-Nov-2023
KDM1A emerged as dual-action therapeutic target for both